Pharma / Biotech

Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.


Related Articles

Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.

Eur J Pharm Biopharm. 2020 Jan 13;:

Authors: Jacqueroux E, Hodin S, Saib S, He Z, Bin V, Delézay O, Delavenne X

Abstract
ABC transporters, such as P-gp and BCRP, are involved in rivaroxaban pharmacokinetics and can lead to drug-drug interactions (DDIs). Investigations of the victim role for rivaroxaban and transporter-mediated DDI are commonly performed using in vitro models. However, interpretation of rivaroxaban efflux transport and DDI studies in cell models may be influenced by P-gp and BCRP transporter abundance. This study aimed to develop an LC-MS/MS quantification method for assessing the relationship between transporter expression and functionality in Caco-2ATCC, Caco-2ECACC, MDCK-MDR1, MDCK-BCRP cell models. First, the relative and absolute quantities of the transporters were determined by LC-MS/MS. P-gp and BCRP expression was then confirmed by western blotting and immunofluorescence staining. Finally, P-gp and BCRP functional activities and half-inhibitory concentrations (IC50s) of two specific inhibitors (verapamil and ko143) were determined by bidirectional transport experiments. P-gp and BCRP protein expression was detected at the cell membrane and was greater in the respective transfected models. Efflux ratios were correlated with P-gp and BCRP quantities. The lowest IC50s were obtained in the MDCK-MDR1 and MDCK-BCRP models for verapamil and ko143, respectively. In conclusion, this study demonstrated that LC-MS/MS can accurately quantify P-gp and BCRP efflux transporters and thereby improve the interpretation of transport data and in vitro-in vivo correlations.

PMID: 31945490 [PubMed – as supplied by publisher]

Source link

Related posts

SULWHASOO EVENFAIR SMOOTHING FOUNDATION SPF25 NO.2 MEDIUM BEIGE (Octinoxate, Titanium Dioxide, And Zinc Oxide) Powder SULWHASOO EVENFAIR SMOOTHING FOUNDATION SPF25 NO.3 MEDIUM OCHER (Octinoxate, Titanium Dioxide, And Zinc Oxide) Powder [Amorepacific Corporation]

Newsemia

ELM (Ulmus Procera, Flos) Liquid [Energique, Inc.]

Newsemia

Translational inhibition of α-synuclein by Posiphen normalizes distal colon motility in transgenic Parkinson mice.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World